Local Google Ads: A Guide to Getting More Calls

Postcode-Cluster Radius Design for Single-Facility Detox

Radius design is where most single-facility campaigns quietly bleed budget. The instinct is to draw the largest defensible circle around the facility and let Google’s location signals sort the rest. The empirical record argues for the opposite discipline. A randomized trial that used Google AdWords to recruit participants across geographically distinct postcode clusters in Britain found that location-targeted internet advertising is feasible at the postcode-area level, and that contamination between intervention and control clusters stays limited when clusters are sufficiently separated ³. The operational translation for detox administrators is direct: geo-targeting is accurate enough to trust at the ZIP-cluster level, but leakage into adjacent areas is a real function of how tightly clusters are drawn and how much buffer sits between them.

For a single-facility detox with one clinical intake team and one admissions phone line, the working radius is the drive-time catchment the facility can actually serve, not the metro. Two design choices follow:

1. Build the primary geo-target as a cluster of ZIP codes inside a 25 to 40 mile drive-time contour, not a concentric circle, because a circle drawn over water, protected land, or a neighboring state pulls calls the facility cannot admit.
2. Treat the ring immediately outside that cluster as a buffer zone with either reduced bids or full exclusion.

The cluster-RCT evidence shows contamination is manageable when clusters are separated; it does not show contamination is zero when they touch ³. Adjacent-metro leakage is the mechanism through which a Denver campaign starts paying for Colorado Springs clicks the facility never wanted.

If you manage multiple facilities: Portfolio Geo-Strategy

The next several paragraphs shift audience. Administrators overseeing two or more detox facilities across a region or state face a geo-problem the single-facility playbook does not solve. Single-facility administrators can skip ahead; the mechanics here apply only to portfolio operators.

The first portfolio decision is whether each facility runs its own campaign or shares one account structure with location-based ad groups. The cluster-RCT finding that contamination stays limited when clusters are properly separated gives portfolio operators a defensible design principle: campaigns for facilities in non-adjacent metros can run in parallel with minimal cross-bidding, while facilities in adjacent metros need explicit exclusion lists to prevent internal cannibalization ³. Two facilities on opposite ends of the same state are independent auctions. Two facilities forty miles apart in the same metro are one auction the operator is bidding against themselves in.

The second decision is call routing. When multiple facilities share a phone tree or a centralized admissions center, the geo-signal from the ad must survive into the routing logic, or the operator loses the ability to attribute admissions back to the correct campaign. Facility-specific tracking numbers per ad group, mapped to the geo-cluster that served the impression, keep attribution intact.

A compact framework for portfolio geo-decisions:

| Variable | Single-facility default | Portfolio adjustment ||—|—|—|| Geo-cluster shape | Drive-time ZIP cluster | Non-overlapping clusters per facility || Buffer zones | Exclude or bid down | Exclude to prevent inter-facility bidding || Location setting | Presence only | Presence only, per facility || Tracking numbers | One per campaign | One per facility-ad group pairing |

Portfolio operators should audit for overlap quarterly. LegitScript certification is facility-specific, and a campaign that drifts across a certified boundary into an uncertified facility’s catchment creates policy exposure the single-facility operator does not carry.

Why Call Extensions Outperform Landing Page Hero Copy for Detox Intent

Detox intent is a phone-first behavior. The searcher is often the patient in crisis, a family member calling from a hospital parking lot, or a discharge planner working a phone tree at shift change. The interaction that matters is voice, not scroll. That behavioral reality argues for a mobile ad architecture in which the call button is the primary conversion surface and the landing page is the fallback.

Empirical work on search advertising strategies documents the mechanism directly. Call extensions let advertisers attach a phone number and a tap-to-call button to mobile search ads at no additional cost, converting the ad unit itself into a conversion surface rather than a click-through to a page ¹⁰. For a detox campaign, that structural detail collapses the funnel from three steps (impression, click, page conversion) to two (impression, call). Every step removed is a percentage of intent that does not leak out to a slow-loading page, a competing browser tab, or a second thought.

The operator implications follow. Call-only ad formats and call extensions should be built into every mobile ad group targeting active detox intent keywords, with call assets scheduled to the hours the admissions line is staffed to answer. Ads that ring an unanswered line during off-hours convert intent into a missed call and, frequently, a call to the next facility in the results. Bid modifiers on mobile devices during staffed hours are the operational lever.

Landing page work still matters, but its role is narrower than consumer-marketing playbooks suggest. The page catches searchers who tap the headline instead of the call button, family members researching before dialing, and desktop traffic that cannot use call extensions at all. Hero copy that describes clinical scope, insurance verification, and admission timelines serves those secondary paths. It does not carry the primary conversion load for the campaign, and budget allocated as if it does misreads how the ad unit actually converts on mobile.

Ad Copy Substantiation: Outcome Claims Inside the FTC Corridor

The creative brief for detox ads runs into a hard wall the moment copy starts describing what treatment achieves. FTC guidance for health products requires that objective claims, express or implied, carry adequate substantiation before the ad runs, and health-related claims specifically must rest on competent and reliable scientific evidence ⁵. Truth-in-advertising rules apply to every claim about detox safety, treatment efficacy, and recovery outcomes, and endorsement and testimonial rules layer on additional constraints for patient quotes and review snippets ⁸.

The substantiation boundary becomes concrete when the copy reaches for outcome numbers. SAMHSA data cited in the joint FDA–FTC opioid warning shows that FDA-approved medication-assisted treatment cuts the risk of death by 50% ². That figure is real, sourced, and defensible, but it describes MAT specifically and mortality specifically. An ad that borrows the shape of that statistic to imply a general “50% better outcomes” claim about a detox program, or that repurposes it as a facility-level success rate, has drifted into an implied claim the facility cannot substantiate. The same warning explicitly names unsubstantiated therapeutic claims as an FTC Act violation ².

The operator translation is a claim-writing rule with two layers:

1. Outcome language should describe what the facility does (medical stabilization, 24-hour physician oversight, MAT induction for eligible patients) rather than what the facility promises the patient will experience.
2. Any statistical claim in an ad must be traceable to the specific study, population, and endpoint it came from, and that trace must survive a regulator reading the ad without the surrounding context.

Copy that fails either test gets rewritten before it enters rotation.

SAMHSA’s communication norms provide a useful tone benchmark alongside the legal one. Their guidance discourages aggressive promotion and repetitive commercial messaging in behavioral health spaces ⁴. Ads written to that standard also tend to land inside the FTC corridor, because restrained, factual copy is harder to read as an implied outcome guarantee than urgency-driven consumer marketing language.

Monument, HIPAA Marketing, and PHI-Safe Conversion Measurement

The conversion measurement stack is where most detox campaigns accumulate silent legal risk. Every pixel, tag, and audience list that touches a patient interaction sits inside HIPAA’s marketing rules, and the 2024 FTC action against Monument set the reference point for what happens when those rules bend. The proposed order banned Monument from disclosing health information for advertising and required affirmative consent before sharing health information with third parties for any other purpose, backed by a suspended $2.5 million civil penalty and a mandated privacy program ¹. The precedent is not that call tracking is illegal. The precedent is that identifiable health information flowing into ad platforms without explicit patient authorization is now a documented enforcement path.

HIPAA’s own definition tightens the frame. HHS guidance holds that a covered entity must obtain an individual’s authorization before using or disclosing protected health information for marketing, with narrow exceptions ⁹. Call recordings, appointment status, insurance verification data, and any field that ties a phone number to a treatment interest all sit inside PHI once they touch the facility’s systems. That means the standard Google Ads conversion setup consumer advertisers use, which passes user-level identifiers and event data back into the platform for optimization, cannot be replicated by a covered entity without either affirmative authorization or a re-architected data flow.

The PHI-safe alternative runs on aggregated, de-identified signals. Call tracking numbers unique to each ad group can pass counts, durations, and geo-cluster attribution back into reporting without exposing caller identity to the ad platform. Server-side conversion imports can be filtered to strip any field that touches clinical status before the data leaves the facility’s environment. Remarketing audiences built from site visitors to treatment-specific pages are the exact use case the Monument order narrows; those lists effectively encode a health inference about every user on them and should be retired or rebuilt from non-health signals such as general brand pages. Administrators treating the ad platform as an untrusted third party, rather than an analytics partner, arrive at the right architecture by default.

Substantiation, Endorsements, and the FTC Health Advertising Standard

The FTC’s substantiation standard operates on a simple principle with sharp edges. Advertisers must have adequate substantiation for all objective claims, express or implied, before an ad runs, and health claims specifically require competent and reliable scientific evidence ⁵. Truth-in-advertising rules apply across every claim about detox safety, success rates, and clinical scope, with no carve-out for shortened ad copy or character-limited headlines ⁸.

Endorsements and reviews carry their own perimeter. Patient testimonials used in ad extensions, sitelinks, or landing pages tied to the ad must reflect typical results, disclose material connections, and avoid implying outcomes the facility cannot substantiate for the general population ⁸. A five-star review quoted in a callout extension reads to a regulator as a facility-endorsed outcome claim, not a neutral aggregation. Facilities that route reviews into ad creative should audit every quote against the substantiation file the facility could actually produce if asked.